Home > Boards > US OTC > Biotechs > Galectin Therapeutics Inc. (GALT)

Thanks for this, I've been watching and holding

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
heartofachild Member Profile
Member Level 
Followed By 4
Posts 60
Boards Moderated 0
Alias Born 01/09/19
160x600 placeholder
UPDATE -- Galectin Therapeutics Announces Commencement of Patient Enrollment of the Adaptively-Designed Phase 2b/3 Trial of B... GlobeNewswire Inc. - 6/30/2020 9:05:53 AM
Galectin Therapeutics Announces Commencement of Patient Enrollment of the Adaptively-Designed Phase 2b/3 Trial of Belapectin ... GlobeNewswire Inc. - 6/30/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/30/2020 7:59:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/26/2020 4:31:45 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/22/2020 6:01:05 AM
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2020, and Provides Business Update GlobeNewswire Inc. - 5/11/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/11/2020 7:49:18 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 5/11/2020 7:47:38 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/11/2020 6:32:31 AM
Galectin Therapeutics Submits Seamless Adaptively-Designed Phase 2b/3 NASH-RX Protocol in NASH Cirrhosis GlobeNewswire Inc. - 4/30/2020 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/30/2020 8:56:06 AM
Galectin Therapeutics Update on the Impact of COVID-19 GlobeNewswire Inc. - 4/2/2020 8:04:03 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/20/2020 8:31:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/17/2020 8:02:22 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/16/2020 4:33:59 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 3/16/2020 4:31:53 PM
Galectin Therapeutics Reports Fiscal 2019 Financial Results and Provides Business Update GlobeNewswire Inc. - 3/16/2020 8:00:10 AM
Galectin Therapeutics Appoints Seasoned Biopharmaceutical Executive Pol F. Boudes, M.D. as Chief Medical Officer GlobeNewswire Inc. - 2/20/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2020 7:55:42 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/14/2020 8:01:59 AM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 2/13/2020 5:00:59 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 2/13/2020 4:37:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/10/2020 4:32:41 PM
Galectin Therapeutics’ President and CEO Dr. Harold Shlevin to Present at the 3rd Global NASH Congress 2020 GlobeNewswire Inc. - 2/4/2020 8:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/21/2020 4:54:52 PM
heartofachild Member Level  Thursday, 02/14/19 12:32:24 AM
Re: goingforittoday post# 3520
Post # of 3677 
Thanks for this, I've been watching and holding


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist